Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
N-(3-(3-(4-(1-Aminocyclobutyl)phenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-5-yl)phenethyl)-1-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-3,6,9,12-tetraoxapentadecan-15-amide
ID: ALA5220162
Chembl Id: CHEMBL5220162
PubChem CID: 139483041
Max Phase: Preclinical
Molecular Formula: C53H58N10O9
Molecular Weight: 979.11
Associated Items: